Leukodystrophies
Guidance for primary care clinicians diagnosing and managing children with leukodystrophies
The leukodystrophies are a group of more than 400 genetic conditions in which the brain's white matter is abnormal due to altered development, decreased amount, or degeneration of the lipid insulation covering neuronal processes in the brain.
Consider a leukodystrophy in any child with developmental delay, global regression, or stops meeting developmental milestones. The diagnosis of a leukodystrophy requires an MRI and biochemical and/or genetic testing; there are no pathognomonic clinical findings. Vigilance for potential complications (growth problems, feeding problems, spasticity, and seizures) permits early intervention. Diagnosis is important and potentially urgent because effective treatments are available within a time-sensitive window.
Key Points
Delay or regression in multiple abilities
Children with leukodystrophy may have delays in their development
or may regress in some combination of language, interaction, motor, fine motor,
and visual abilities.
Myelin varies by age
Because the appearance of myelin in children of different ages
varies, MRIs should be performed in a facility where pediatric neuroradiologists
are available to interpret the scans.
Swallowing issues may become a problem
Swallowing difficulty may lead to long feeding times, weight loss,
and aspiration pneumonias. If suspected, swallowing difficulty should be
evaluated by periodic swallow studies. Treatment consists of alternative feeding
approaches, such as a gastrostomy tube. See Feeding Tubes & Gastrostomies in Children.
Poor weight gain
Swallowing difficulty may lead to long feeding times, weight loss,
and aspiration pneumonias. If suspected, swallowing difficulty should be
evaluated by periodic swallow studies. Treatment consists of alternative feeding
approaches, such as a gastrostomy tube. See Boosting Calories for Babies, Toddlers, and Older Children.
Development (Cognitive, Motor, Language, Social-Emotional)
Collaborate with teachers and school personnel to advocate for
services such as an IEP and 504 Plan. School Accommodations: IEPs & 504s provides
ideas for facilitating this type of communication.
Practice Guidelines
Parikh S, Bernard G, Leventer RJ, van der Knaap MS, van Hove J, Pizzino A, McNeill NH, Helman G, Simons C, Schmidt JL, Rizzo
WB, Patterson MC, Taft RJ, Vanderver A.
A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies.
Mol Genet Metab.
2015;114(4):501-15.
PubMed abstract / Full Text
Adang LA, Sherbini O, Ball L, Bloom M, Darbari A, Amartino H, DiVito D, Eichler F, Escolar M, Evans SH, Fatemi A, Fraser J,
Hollowell L, Jaffe N, Joseph C, Karpinski M, Keller S, Maddock R, Mancilla E, McClary B, Mertz J, Morgart K, Langan T, Leventer
R, Parikh S, Pizzino A, Prange E, Renaud DL, Rizzo W, Shapiro J, Suhr D, Suhr T, Tonduti D, Waggoner J, Waldman A, Wolf NI,
Zerem A, Bonkowsky JL, Bernard G, van Haren K, Vanderver A.
Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies.
Mol Genet Metab.
2017;122(1-2):18-32.
PubMed abstract
Bonkowsky JL, Keller S.
Leukodystrophies in Children: Diagnosis, Care, and Treatment.
Pediatrics.
2021.
PubMed abstract
Diagnosis
Presentations
Diagnostic Criteria and Classifications
Diagnostic Testing & Screening
Laboratory Testing
Newborn screening for some leukodystrophies is performed in certain states. Routine developmental screening will identify many children affected by leukodystrophies.
Once abnormalities consistent with a leukodystrophy are identified on brain MRI, leukocyte lysosomal enzyme testing, tissue biopsy, genetic testing or other molecular DNA analyses can sometimes help pinpoint diagnose a specific leukodystrophy. This information may be important in guiding therapy,
Imaging
Genetics
Incidence & Prevalence
Differential Diagnosis
Leukodystrophy should be suspected if a child thought to have CP is experiencing a progression of disability or a slowing of developmental achievement, particularly when there is no apparent antecedent for the CP. For example, the CP Spectrum Disorders Panel (Invitae Labs) analyzes a broad panel of genes to identify a possible genetic origin for cerebral palsy. Cerebral Palsy has further details.
Consider demyelinating diseases (primarily multiple sclerosis and neuromyelitis optica) as differential diagnoses.
Prognosis
Some leukodystrophies present with impairment from birth and do not progress, while others have progressive deterioration in neurologic function. In general, leukodystrophies are severe diseases. In a large cohort, only 51% of children walked and 28% achieved the ability to track visually. [Bonkowsky: 2010] In a few leukodystrophies, hematopoietic stem cell transplantation (bone marrow transplantation) can prevent primary disease manifestations if performed early in the disease course. [Pagon: 2014]
Treatment & Management
When a leukodystrophy is identified, the possibility of an existing treatment should be considered with the child’s geneticist/neurologist. There are multiple existing treatments, and more are expected in the near future. Some treatments only work in pre-symptomatic or early symptomatic stages, so rapid diagnosis is important.
Next, existing abilities should be evaluated, and rehabilitation should be provided to help regain function or to prevent further deterioration as much as possible. Psychiatric symptoms may be the first to present in older children, adolescents, and adults. Seizures may occur as presenting or early symptoms. Endocrine abnormalities (hypothyroidism, diabetes, and others) are also observed and should be looked for on diagnosis. Spasticity may limit movement and cause pain in some children and should be monitored for over time.
Neurology
Dental
Referrals & Services
The benefit of subspecialist involvement may increase as the child becomes progressively more affected. Balance the benefit of subspecialty help with the family's wishes and convenience of services. Coordination of care among subspecialists, therapists, school, and community services will help optimize outcomes, minimize duplication of services, and ensure the family's goals are addressed. The medical home clinician may need to be involved with the individual education plan (IEP) to ensure the child receives needed school services. A teacher coming to the home to work with the child may be helpful in some cases.
Pediatric Neurology
(see NV providers
[5])
Involve in the diagnosis and periodic assessments. Consider referral
for monitoring developmental progress. Depending on the frequency of seizures and
the response to medications, consider consultative or co-management care.
Neurologists can also monitor neurological changes and suggest or manage
interventions.
Medical Genetics
(see NV providers
[5])
Consider for specific genetic diagnosis.
Pediatric Ophthalmology
(see NV providers
[6])
Consider involving to diagnose certain forms of
leukodystrophy.
Developmental - Behavioral Pediatrics
(see NV providers
[3])
Refer for help monitoring developmental progress and academic
achievement and suggesting or coordinating interventions when
necessary.
Pediatric Ophthalmology
(see NV providers
[6])
Consider involving to diagnose certain forms of
leukodystrophy.
Pediatric Physical Medicine & Rehabilitation
(see NV providers
[3])
Consider for help in managing spasticity, impairments in walking,
and the activities of daily living.
Pediatric Dentistry
(see NV providers
[28])
Refer to monitor dental health and treat as necessary. Some issues
that affect dental care are problems handling saliva, reflux, mouths that do not
open well, and the need for sedation for cleaning and other procedures.
CSHCN Clinics
(see NV providers
[5])
In some
locales, children may be able to receive care from a specialty
clinic.
E75.29, Other sphingolipidoses
Further coding details can be found by using the search feature at ICD10Data.com.
Resources
Information & Support
Related Portal Content
- Intellectual Disability & Global Developmental Delay
- Cerebral Palsy
- Intellectual Disability and Global Developmental Delay (FAQ)
- Cerebral Palsy (FAQ)
- Care Notebook
- Leukodystrophies (FAQ)
For Professionals
Leukodystrophies (OMIM)
Information about clinical features, diagnosis, management, and molecular and population genetics; Online Mendelian Inheritance
in Man, authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine
MRI Images of Leukodystrophies (RadioGraphics)
Examples of MRIs of common leukodystrophies; Radiological Society of North America.
For Parents and Patients
United Leukodystrophy Foundation (ULF)
A non-profit organization dedicated to funding cutting-edge research and providing patients and their families with disease
information and medical referrals.
Leukodystrophies (MedlinePlus)
Information for families that includes description, frequency, causes, inheritance, other names, and additional resources;
from the National Library of Medicine.
Leukodystrophy (NORD)
Information for families that includes synonyms, signs & symptoms, causes, affected populations, related disorders, diagnosis,
therapies (both standard and investigational), and support organizations; National Organization of Rare Disorders.
United Leukodystrophy Foundation Support Community
An online support community providing opportunities to connect with other families of children with leukodystrophies; free
sign-up required.
Services for Patients & Families in Nevada (NV)
Service Categories | # of providers* in: | NV | NW | Other states (3) (show) | | NM | RI | UT |
---|---|---|---|---|---|---|---|---|
CSHCN Clinics | 5 | 2 | 4 | 13 | 5 | |||
Developmental - Behavioral Pediatrics | 3 | 1 | 2 | 12 | 9 | |||
Medical Genetics | 5 | 1 | 2 | 4 | 7 | |||
Pediatric Dentistry | 28 | 2 | 6 | 59 | 50 | |||
Pediatric Neurology | 5 | 5 | 18 | 8 | ||||
Pediatric Ophthalmology | 6 | 1 | 6 | 8 | 4 | |||
Pediatric Physical Medicine & Rehabilitation | 3 | 3 | 3 | 6 | 11 |
For services not listed above, browse our Services categories or search our database.
* number of provider listings may vary by how states categorize services, whether providers are listed by organization or individual, how services are organized in the state, and other factors; Nationwide (NW) providers are generally limited to web-based services, provider locator services, and organizations that serve children from across the nation.
Studies
Leukodystrophy (clinicaltrials.gov)
Studies looking at better understanding, diagnosing, and treating this condition; from the National Library of Medicine.
Helpful Articles
Adang L.
Leukodystrophies.
Continuum (Minneap Minn).
2022;28(4):1194-1216.
PubMed abstract
Ashrafi MR, Amanat M, Garshasbi M, Kameli R, Nilipour Y, Heidari M, Rezaei Z, Tavasoli AR.
An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.
Expert Rev Neurother.
2020;20(1):65-84.
PubMed abstract
Keller SR, Mallack EJ, Rubin JP, Accardo JA, Brault JA, Corre CS, Elizondo C, Garafola J, Jackson-Garcia AC, Rhee J, Seeger
E, Shullanberger KC, Tourjee A, Trovato MK, Waldman AT, Wallace JL, Wallace MR, Werner K, White A, Ess KC, Becker C, Eichler
FS.
Practical Approaches and Knowledge Gaps in the Care for Children With Leukodystrophies.
J Child Neurol.
2021;36(1):65-78.
PubMed abstract / Full Text
Page KM, Stenger EO, Connelly JA, Shyr D, West T, Wood S, Case L, Kester M, Shim S, Hammond L, Hammond M, Webb C, Biffi A,
Bambach B, Fatemi A, Kurtzberg J.
Hematopoietic Stem Cell Transplantation to Treat Leukodystrophies: Clinical Practice Guidelines from the Hunter's Hope Leukodystrophy
Care Network.
Biol Blood Marrow Transplant.
2019;25(12):e363-e374.
PubMed abstract
Authors & Reviewers
Author: | Lynne M. Kerr, MD, PhD |
Reviewer: | Joshua L Bonkowsky, MD, PhD |
2019: update: Lynne M. Kerr, MD, PhDA; Joshua L Bonkowsky, MD, PhDR |
2015: update: Joshua L Bonkowsky, MD, PhDA; Meghan S Candee, MD, MScR |
2011: first version: Lynne M. Kerr, MD, PhDA |
Page Bibliography
Adang L.
Leukodystrophies.
Continuum (Minneap Minn).
2022;28(4):1194-1216.
PubMed abstract
Adang LA, Sherbini O, Ball L, Bloom M, Darbari A, Amartino H, DiVito D, Eichler F, Escolar M, Evans SH, Fatemi A, Fraser J,
Hollowell L, Jaffe N, Joseph C, Karpinski M, Keller S, Maddock R, Mancilla E, McClary B, Mertz J, Morgart K, Langan T, Leventer
R, Parikh S, Pizzino A, Prange E, Renaud DL, Rizzo W, Shapiro J, Suhr D, Suhr T, Tonduti D, Waggoner J, Waldman A, Wolf NI,
Zerem A, Bonkowsky JL, Bernard G, van Haren K, Vanderver A.
Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies.
Mol Genet Metab.
2017;122(1-2):18-32.
PubMed abstract
Ashrafi MR, Amanat M, Garshasbi M, Kameli R, Nilipour Y, Heidari M, Rezaei Z, Tavasoli AR.
An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.
Expert Rev Neurother.
2020;20(1):65-84.
PubMed abstract
Bonkowsky JL, Keller S.
Leukodystrophies in Children: Diagnosis, Care, and Treatment.
Pediatrics.
2021.
PubMed abstract
Bonkowsky JL, Nelson C, Kingston JL, Filloux FM, Mundorff MB, Srivastava R.
The burden of inherited leukodystrophies in children.
Neurology.
2010;75(8):718-25.
PubMed abstract / Full Text
Bonkowsky JL, Wilkes J, Bardsley T, Urbik VM, Stoddard G.
Association of Diagnosis of Leukodystrophy With Race and Ethnicity Among Pediatric and Adolescent Patients.
JAMA Netw Open.
2018;1(7):e185031.
PubMed abstract / Full Text
Keller SR, Mallack EJ, Rubin JP, Accardo JA, Brault JA, Corre CS, Elizondo C, Garafola J, Jackson-Garcia AC, Rhee J, Seeger
E, Shullanberger KC, Tourjee A, Trovato MK, Waldman AT, Wallace JL, Wallace MR, Werner K, White A, Ess KC, Becker C, Eichler
FS.
Practical Approaches and Knowledge Gaps in the Care for Children With Leukodystrophies.
J Child Neurol.
2021;36(1):65-78.
PubMed abstract / Full Text
Page KM, Stenger EO, Connelly JA, Shyr D, West T, Wood S, Case L, Kester M, Shim S, Hammond L, Hammond M, Webb C, Biffi A,
Bambach B, Fatemi A, Kurtzberg J.
Hematopoietic Stem Cell Transplantation to Treat Leukodystrophies: Clinical Practice Guidelines from the Hunter's Hope Leukodystrophy
Care Network.
Biol Blood Marrow Transplant.
2019;25(12):e363-e374.
PubMed abstract
Pagon RA, Adam MP, Ardinger HH, et al.
Leukodystrophy Overview.
GeneReviews® ; (2014)
http://www.ncbi.nlm.nih.gov/books/NBK184570/. Accessed on October 2015.
Parikh S, Bernard G, Leventer RJ, van der Knaap MS, van Hove J, Pizzino A, McNeill NH, Helman G, Simons C, Schmidt JL, Rizzo
WB, Patterson MC, Taft RJ, Vanderver A.
A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies.
Mol Genet Metab.
2015;114(4):501-15.
PubMed abstract / Full Text
Richards J, Korgenski EK, Taft RJ, Vanderver A, Bonkowsky JL.
Targeted leukodystrophy diagnosis based on charges and yields for testing.
Am J Med Genet A.
2015;167A(11):2541-3.
PubMed abstract / Full Text
Rosenberg JB, Kaminsky SM, Aubourg P, Crystal RG, Sondhi D.
Gene therapy for metachromatic leukodystrophy.
J Neurosci Res.
2016;94(11):1169-79.
PubMed abstract / Full Text
Soderholm HE, Chapin AB, Bayrak-Toydemir P, Bonkowsky JL.
Elevated Leukodystrophy Incidence Predicted From Genomics Databases.
Pediatr Neurol.
2020;111:66-69.
PubMed abstract / Full Text
Soderholm HE, Chapin AB, Bayrak-Toydemir P, Bonkowsky JL.
Elevated Leukodystrophy Incidence Predicted From Genomics Databases.
Pediatr Neurol.
2020;111:66-69.
PubMed abstract / Full Text
Urbik VM, Schmiedel M, Soderholm H, Bonkowsky JL.
Expanded Phenotypic Definition Identifies Hundreds of Potential Causative Genes for Leukodystrophies and Leukoencephalopathies.
Child Neurol Open.
2020;7:2329048X20939003.
PubMed abstract / Full Text